Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma

Frederick Thielen; NC Büyükkaramikli; R Riemsma; D Fayter; N Armstrong; C-Y Wei; V Huertas Carrera; K Misso; G Worthy; J Kleijnen; Isaac Corro Ramos

doi:10.1007/s40273-018-0740-4

Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma

Frederick Thielen, NC Büyükkaramikli, R Riemsma, D Fayter, N Armstrong, C-Y Wei, V Huertas Carrera, K Misso, G Worthy, J Kleijnen, Isaac Corro Ramos

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

8 Downloads (Pure)

Original language	English
Journal	Pharmacoeconomics (Print)
DOIs	https://doi.org/10.1007/s40273-018-0740-4
Publication status	Published - 13 Dec 2018

Access to Document

10.1007/s40273-018-0740-4

Repub_113376_O-A.pdfFinal published version, 852 KB

http://hdl.handle.net/1765/113376

Cite this

@article{af0c53262dc84b9d865f563a2a7071d5,

title = "Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma",

author = "Frederick Thielen and NC B{\"u}y{\"u}kkaramikli and R Riemsma and D Fayter and N Armstrong and C-Y Wei and {Huertas Carrera}, V and K Misso and G Worthy and J Kleijnen and {Corro Ramos}, Isaac",

year = "2018",

month = dec,

day = "13",

doi = "10.1007/s40273-018-0740-4",

language = "English",

journal = "Pharmacoeconomics (Print)",

issn = "1170-7690",

publisher = "Adis",

}

TY - JOUR

T1 - Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma

AU - Thielen, Frederick

AU - Büyükkaramikli, NC

AU - Riemsma, R

AU - Fayter, D

AU - Armstrong, N

AU - Wei, C-Y

AU - Huertas Carrera, V

AU - Misso, K

AU - Worthy, G

AU - Kleijnen, J

AU - Corro Ramos, Isaac

PY - 2018/12/13

Y1 - 2018/12/13

UR - https://link.springer.com/article/10.1007/s40273-018-0740-4

U2 - 10.1007/s40273-018-0740-4

DO - 10.1007/s40273-018-0740-4

M3 - Article

SN - 1170-7690

JO - Pharmacoeconomics (Print)

JF - Pharmacoeconomics (Print)

ER -

Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma

Access to Document

Other files and links

Cite this